HIKAL LTD.

Hikal Ltd has announced that its Board of Directors will convene on November 3, 2026. The primary agenda for this meeting is to consider, approve, and take on record the standalone and consolidated unaudited financial results for the second quarter and half year ended September 30, 2026.

Hikal Ltd announced that Mrs. Sugandha Hiremath has resigned as a Non-Executive Director, effective September 30, 2026, due to personal commitments. The Board of Directors accepted her resignation. Concurrently, the company noted the cessation of Mr. Jai Hiremath's term as Executive Chairman on October 1, 2026. Mr. Jai Hiremath will be conferred the honorary position of "Chairman Emeritus" for five years. Mr. Anish Swadi has been appointed as CEO-Animal Health and Specialty Ingredients.

Hikal Ltd announced significant management changes following a Board Meeting on October 01, 2026. Mr. Jai Hiremath has ceased his term as Executive Chairman, with effect from October 01, 2026, and will assume the honorary position of "Chairman Emeritus" for five years. Mrs. Sugandha Hiremath resigned as Non-Executive Director due to personal commitments, effective September 30, 2026. The Board also approved the appointment of Mr. Anish Swadi as CEO-Animal Health and Specialty Ingredients, effective October 01, 2026. These changes follow the recommendations of the Nomination and Remuneration Committee.

Hikal Ltd's Board of Directors met on October 01, 2026. Key outcomes include the cessation of Mr. Jai Hiremath's term as Executive Chairman, effective the same date. The Board acknowledged his significant contributions over nearly four decades. Mrs. Sugandha Hiremath resigned as Non-Executive Director due to personal commitments. The Board approved conferring the honorary position of "Chairman Emeritus" upon Mr. Jai Hiremath for five years, recognizing his past services. Additionally, Mr. Anish Swadi was appointed as CEO-Animal Health and Specialty Ingredients, a senior management position, effective October 01, 2026. The meeting commenced at 11:30 a.m. and concluded at 1:12 p.m.

Hikal Ltd has been assigned an ESG Rating of "Crisil ESG 65" for FY 2025-26 by Crisil ESG Ratings & Analytics Limited. The rating was provided independently based on publicly available data. Hikal's performance was noted for its renewable energy consumption mix, high waste recycling rate, low water withdrawal from water-stressed areas, employee skill upgradation and safety, low customer and stakeholder complaints, zero safety incidents, and adequate board strength with a high share of women directors and high independent director attendance. The company did not engage Crisil ESG Ratings for this rating.

Hikal Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from October 01, 2026, and will reopen 48 hours after the declaration of the financial results for the quarter and half-year ending September 30, 2026. This measure is standard practice to prevent potential insider trading before the official disclosure of financial information.

Hikal Ltd conducted its 38th Annual General Meeting (AGM) on September 23, 2026, via Video Conferencing. The meeting transacted six resolutions, including the adoption of audited standalone and consolidated financial statements for FY 2025-26. The company provided a summary of proceedings and the consolidated scrutinizer's report on e-voting, which will be uploaded on the company's website. The AGM concluded with the voting results being shared as per SEBI Listing Regulations.

Hikal Ltd shareholders have approved the appointment of Mr. Sameer Hiremath as Chairman & Managing Director for a five-year term, effective October 1, 2026. The approval was granted at the company's 38th Annual General Meeting. Shareholders also approved the audited financial statements for FY2025-26, a final dividend of Rs. 0.40, and the re-appointment of Mr. Sarangan Suresh as Executive Director. The company also announced the commencement of commercial production of Personal Care products at its new facility in Gujarat and highlighted its EcoVadis Gold Medal rating for sustainability.

Hikal Limited has commenced commercial production at its new cGMP-compliant, multipurpose manufacturing facility in Panoli, Gujarat, marking its entry into the commercial-scale Personal Care market. The facility will initially focus on second-generation UV filters for the skin care category, leveraging Hikal's expertise in process chemistry and regulatory manufacturing. The company has received positive feedback on initial product samples from global and domestic partners, indicating a strong market pull. This expansion into Personal Care is part of Hikal's strategy to build new, high-value growth platforms alongside its existing Pharmaceutical, Crop Protection, and Animal Health businesses. The company also recently commissioned a new cGMP pilot plant for pharmaceutical process development and received an EcoVadis Gold Medal for sustainability.

Hikal Ltd has informed its members, particularly those without registered email addresses, about the availability of its Annual Report for the Financial Year 2025-26. The company is providing a weblink and the exact path on its website where the complete report can be accessed, in compliance with SEBI (LODR) Regulations, 2015. This communication also serves as a reminder for members to update their KYC details and dematerialize physical securities, with specific forms and SEBI circulars available on the company's investor relations portal. The 38th Annual General Meeting is scheduled for September 23, 2026.